Back

The current landscape of lifestyle and other non-pharmaceutical interventions in oncology in Africa: A review of registered clinical trials

Wangari, M.; Njoroge, E.; Mburu, G.; Mogeni, B. K.; Ouma, L.

2025-01-28 public and global health
10.1101/2025.01.26.25321157 medRxiv
Show abstract

Cancer is a significant public health issue in low--and middle-income countries, especially in Africa. While lifestyle and/or behavioral interventions such as exercise and dietary modifications are known to improve patient outcomes and quality of life, critical evidence from resource-limited settings like Africa is scanty. Here, we present a review of clinical trials on the current landscape of cancer associated lifestyle interventions in oncology in Africa. We comprehensively reviewed non-pharmacological/ lifestyle cancer-related clinical trials in Africa on ClinicalTrials.gov and ICTRP trial registries from 01 July 2005 to 30 October 2024. We employed descriptive analyses, primarily frequency and percentage, to analyze and report the data. Overall, 53 trials matching the criteria were identified. Most of the trials were in Egypt (38/53, 97.4%), Kenya (4/53,10.3%), and Nigeria (5/53, 12.9%). The top cancer types for the trials in Africa were breast 24/62, 45.3%), colorectal (6/62, 11.3%) and acute lymphoblastic leukemia (4/62, 7.5%). Concerning sponsorship, most trials were universities/academia-sponsored trials (45/53, 84.9%), locally sponsored (37/53, 69.8%), conducted among patients (88.7%), and 84.9% cancer survivors. Most trials involved physical activity interventions (25/53, 47.2%) and psychological and psychological interventions (10/53, 18.9%), with (32/53, 60.4%) trials completed and (13/53, 24.5%) trials ongoing. Non-pharmacological interventions for the management of cancer appear to be nascent in Africa. Oncology trials are needed to ensure the effectiveness of non-pharmaceutical/lifestyle interventions in Africa, especially sub-Saharan Africa (SSA). In the current era of precision medicine, pharmacological, and lifestyle interventions, it no longer suffices to assume that interventions in high--and upper-middle-income countries will be effective in low-middle-income countries, especially Africa.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
BMC Cancer
52 papers in training set
Top 0.1%
38.8%
2
PLOS ONE
4510 papers in training set
Top 15%
12.7%
50% of probability mass above
3
Cancer Medicine
24 papers in training set
Top 0.1%
6.5%
4
eLife
5422 papers in training set
Top 28%
3.3%
5
Scientific Reports
3102 papers in training set
Top 40%
3.2%
6
BMJ Open
554 papers in training set
Top 8%
2.1%
7
BMJ Global Health
98 papers in training set
Top 2%
1.5%
8
International Journal of Cancer
42 papers in training set
Top 0.7%
1.5%
9
Frontiers in Medicine
113 papers in training set
Top 4%
1.3%
10
Nature Medicine
117 papers in training set
Top 3%
1.3%
11
eBioMedicine
130 papers in training set
Top 3%
1.0%
12
Trials
25 papers in training set
Top 1%
1.0%
13
Journal of Clinical Epidemiology
28 papers in training set
Top 0.5%
0.9%
14
International Journal of Infectious Diseases
126 papers in training set
Top 3%
0.8%
15
Human Vaccines & Immunotherapeutics
25 papers in training set
Top 0.7%
0.8%
16
Cancers
200 papers in training set
Top 4%
0.8%
17
BMC Medicine
163 papers in training set
Top 6%
0.8%
18
npj Precision Oncology
48 papers in training set
Top 1%
0.8%
19
Annals of Internal Medicine
27 papers in training set
Top 0.9%
0.8%
20
F1000Research
79 papers in training set
Top 4%
0.8%
21
BMC Public Health
147 papers in training set
Top 6%
0.8%
22
Contemporary Clinical Trials Communications
11 papers in training set
Top 0.6%
0.8%
23
PLOS Global Public Health
293 papers in training set
Top 6%
0.7%
24
JCO Precision Oncology
14 papers in training set
Top 0.4%
0.7%
25
Cancer Letters
32 papers in training set
Top 0.8%
0.7%
26
Aging
69 papers in training set
Top 3%
0.7%
27
Journal of Translational Medicine
46 papers in training set
Top 4%
0.5%
28
Frontiers in Public Health
140 papers in training set
Top 9%
0.5%
29
Clinical Infectious Diseases
231 papers in training set
Top 6%
0.5%
30
Nature Communications
4913 papers in training set
Top 67%
0.5%